# Clinical Study in the Treatment of Patients With Moderate Course of COVID-19

> **NCT04842435** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Microgen** · enrollment: 376 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** COVID-globulin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04842435
- **Lead sponsor:** Microgen
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-12
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-10-05
- **Target enrollment:** 376 (ESTIMATED)
- **Last updated:** 2021-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04842435

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04842435, "Clinical Study in the Treatment of Patients With Moderate Course of COVID-19". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04842435. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*